Creon 180000 [USP'U]/1

Creon 180000 [USP'U]/1 is a delayed-release pancreatic enzyme supplement designed to aid digestion. It contains pancrelipase, which helps break down fats, proteins, and carbohydrates. This medication is commonly used for individuals with exocrine pancreatic insufficiency.

Creon 180000 [USP'U]/1 is primarily used to manage digestive issues related to exocrine pancreatic insufficiency. This condition occurs when the pancreas does not produce enough digestive enzymes. The medication helps to break down fats, proteins, and carbohydrates in the digestive system, facilitating better nutrient absorption. People with conditions like chronic pancreatitis or cystic fibrosis may benefit from this enzyme supplement.

Creon 180000 [USP'U]/1 works by supplementing the digestive enzymes that the pancreas would normally produce. This can help alleviate symptoms such as bloating, gas, and diarrhea. The delayed-release pellets are designed to resist stomach acid and release the enzymes in the small intestine, where they are most effective.

Creon 180000 [USP'U]/1 should be taken as directed by a healthcare professional. It is important to swallow the capsules whole and not chew or crush them, as this can damage the delayed-release mechanism. Always follow the prescribed dosage and consult a healthcare provider before making any changes to your medication regimen.

Creon 180000 [USP'U]/1 may interact with certain medications, particularly those that affect stomach acid levels. It is important to inform your healthcare provider about all the medications you are taking, including over-the-counter drugs and supplements. Additionally, some foods and beverages, such as high-fiber foods, may affect the absorption of the enzymes.